Brooks Laboratories Ltd share price logo

Brooks Laboratories Ltd (BROOKS)

₹82.541.25%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Performance

  • Day's Low

    Day's High

    ₹80.1
    ₹84
  • 52 Week's Low

    52 Week's High

    ₹61.21
    ₹185.7
1 Month Return-16.99 %
3 Month Return-20.47 %
1 Year Return+ 29.81 %
Previous Close₹81.52
Open₹82.05
Volume44.90K
Upper Circuit-
Lower Circuit-
Market Cap₹213.96Cr

Company Information

Brooks Laboratories Ltd is an esteemed pharmaceutical manufacturing company that has established plants in Baddi, Himachal Pradesh and Vadodara, Gujarat. The Vadodara facility was approved by the European Medicine Agency, and the company’s product portfolio consists of 28 injectables, 19 tablets and 2 dry syrups that are catered to the critical care segment. They are sourced from suppliers like Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd, and served to clients like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd and Sanat Products Ltd.

Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.

Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.

Share Price: ₹82.54 per share as on 12 Jun, 2024 04:01 PM
Market Capitalisation: ₹213.96Cr as of today
Revenue: ₹17.72Cr as on March 2024 (Q1 24)
Net Profit: ₹-9.61Cr as on March 2024 (Q1 24)
Listing date: 05 Sep, 2011
OrganisationBrooks Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Insights on Brooks Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 121.5% return, outperforming this stock by 140.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.59% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 32.55% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 112.7% return, outperforming this stock by 82.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BROOKS stock has moved down by -17.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 24.41 Cr → 18.38 Cr (in ₹), with an average decrease of 13.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.64 Cr → -9.61 Cr (in ₹), with an average decrease of 142.1% per quarter

Brooks Laboratories Ltd Valuation

Brooks Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-31.14x)

January 11, 2024

Today (-10.57x)

June 11, 2024

Industry (64.94x)

June 11, 2024

Highest (-5.43x)

May 25, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
Quant Business Cycle Fund Direct GrowthQuant Business Cycle Fund Direct Growth0.33%
Quant Healthcare Fund Direct GrowthQuant Healthcare Fund Direct Growth1.36%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
63.59%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
3.86%
0.00
Retail Investors
32.55%
0.00
Others
0%
0.00

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Brooks Laboratories Ltd shares.

Brooks Laboratories Ltd (BROOKS) share price today is ₹82.54

Brooks Laboratories Ltd is listed on NSE

Brooks Laboratories Ltd is listed on BSE

  • Today’s highest price of Brooks Laboratories Ltd is ₹84.
  • Today’s lowest price of Brooks Laboratories Ltd is ₹80.1.

PE Ratio of Brooks Laboratories Ltd is -10.57

PE ratio = Brooks Laboratories Ltd Market price per share / Brooks Laboratories Ltd Earnings per share

Today’s traded volume of Brooks Laboratories Ltd(BROOKS) is 44.90K.

Today’s market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹213.96Cr.

Brooks Laboratories Ltd(BROOKSPrice
52 Week High
₹185.7
52 Week Low
₹61.21

Brooks Laboratories Ltd(BROOKS) share price is ₹82.54. It is down -55.55% from its 52 Week High price of ₹185.7

Brooks Laboratories Ltd(BROOKS) share price is ₹82.54. It is up 34.85% from its 52 Week Low price of ₹61.21

Brooks Laboratories Ltd(BROOKSReturns
1 Day Returns
1.02%
1 Month Returns
-16.99%
3 Month Returns
-20.47%
1 Year Returns
29.81%